Keith Speights

Recent Articles by Keith Speights

Why Amgen Will Likely Be A Boring Dividend Stock Over The Next Few Years
By Keith Speights | September 13, 2018 |
This big biotech might look more like a big pharma with sluggish growth but great dividends -- at least temporarily.
Get Paid While You Wait: 3 Top Dividend Stocks In Healthcare
By Keith Speights | August 07, 2018 |
Three of the best dividends -- and best businesses -- in healthcare.
Is Johnson & Johnson A Buy?
By Keith Speights | July 17, 2018 |
The healthcare giant has stumbled lately, but J&J still has plenty to offer investors.
Here's My Top Stock To Buy In July
By Keith Speights | July 05, 2018 |
This stock is a cash cow with a strong moat and great growth prospects.
CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic
By Keith Speights | June 13, 2018 |
Newly identified potential issues with CRISPR-Cas9 gene editing aren't as worrisome as you might think.
3 Stocks To Supplement Your Social Security Income
By Keith Speights | June 12, 2018 |
These stocks have what it takes to help meet your financial needs in retirement beyond what Social Security can provide.
Better Buy: Veeva Systems Inc. Vs. athenahealth, Inc.
By Keith Speights | June 07, 2018 |
Which cloud-based healthcare technology stock wins in a head-to-head matchup?
2 Cheap Dividend Stocks You Can Buy Right Now
By Keith Speights | June 06, 2018 |
These two drug stocks have a lot to offer income investors and value investors.
Buy These 2 Biotech Stocks On The Dip After An FDA Delay
By Keith Speights | June 05, 2018 |
Here's why terrific results for a revolutionary new cancer therapy left investors unsatisfied.
3 Common Denominators Of My 3 Best-Performing Stocks Of 2018 So Far
By Keith Speights | June 01, 2018 |
These hot stocks are more alike than they might appear at first glance.